MUFG increases stake in Australian Clinical Labs

Mitsubishi UFJ Financial Group, Inc. has reported a change in its substantial holding in Australian Clinical Labs Limited, with its voting power increasing from 7.13% to 8.74%. The change in interest was recorded on October 15, 2025, with awareness of the change noted on October 17, 2025. The previous notification was dated August 29, 2025.

The total number of votes attached to the shares held by MUFG has risen from 14,007,561 to 17,120,818 fully paid ordinary shares. This increase reflects a series of acquisition activities, including purchases of securities by entities controlled by Morgan Stanley and First Sentier Group Limited, which MUFG has voting power over.

Transactions listed in the annexures detail numerous purchases and sales of shares across various dates in August, September, and October 2025. Notable acquisitions include those by First Sentier Group Limited, with transactions such as A$459,310.28 for 168,740 shares on September 1, 2025, and A$172,817.93 for 69,141 shares on October 3, 2025.